Storing Klow 80mg: Best Practices
Recommended Laboratory Storage Conditions — KLOW Blend (80 mg)
Lyophilized Powder: Store at −20°C (−4°F) for long-term stability (12–24 months). The blend stability window is constrained by the most thermolabile component — for KLOW this is TB-500 and KPV. BPC-157 is unusually stable at room temperature, and GHK-Cu is robust below 25°C, but the blend should be handled to the strictest member's specification. Use desiccant; protect from direct light.
Reconstituted Solution: Reconstitute with sterile or bacteriostatic water for injection. Refrigerate at 2–8°C (36–46°F) and use within 7–14 days. Solution should appear clear with a pale blue–violet tint (the GHK-Cu chromophore); cloudy or colorless solutions indicate compromised material.
Handling: Standard aseptic technique with PPE (gloves, lab coat). Avoid repeated freeze-thaw cycles — peptide blends with a copper-complex component are particularly sensitive to oxidative degradation under thermal cycling.
Compatibility note: All four peptides are pre-co-lyophilized at point of manufacture. Do not split or partition the powder physically; the homogeneity of the 50/10/10/10 ratio is only guaranteed when the entire vial is reconstituted in one step.
References
- Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide. International Journal of Molecular Sciences. 2018;19(7):1987.
- Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways. BioMed Research International. 2015;2015:648108.
- Sikiric P, et al. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Current Pharmaceutical Design. 2011;17(16):1612-1632.
- Dalmasso G, et al. PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation. Gastroenterology. 2008;134(1):166-178.
- U.S. Food and Drug Administration. Certain Bulk Drug Substances for Use in Compounding. FDA.gov. Updated 2023.
- Hsieh MJ, et al. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation. Journal of Molecular Medicine. 2017;95(3):323-333.
- Goldstein AL, et al. Thymosin β4: a multi-functional regenerative peptide. Expert Opinion on Biological Therapy. 2012;12(1):37-51.
- Philp D, Goldstein AL, Kleinman HK. Thymosin beta4 promotes angiogenesis, wound healing, and hair follicle development. Mechanisms of Ageing and Development. 2004;125(2):113-115.
- Brzoska T, et al. α-Melanocyte-Stimulating Hormone and Related Tripeptides. Endocrine Reviews. 2008;29(5):581-602.
- Park JR, et al. The tri-peptide GHK-Cu complex ameliorates lipopolysaccharide-induced acute lung injury. Oncotarget. 2016;7(36):58405-58417.
- Sikiric P, et al. Brain-gut axis and pentadecapeptide BPC 157. Current Neuropharmacology. 2016;14(8):857-865.
- Rahaman KA, et al. Simultaneous quantification of TB-500 and its metabolites. Journal of Chromatography B. 2024;1235:124033.
- Kannengiesser K, et al. KPV has anti-inflammatory potential in murine IBD models. Inflammatory Bowel Diseases. 2008;14(3):324-331.
- Xiao B, et al. Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles. Molecular Therapy. 2017;25(7):1628-1640.
Related Research Questions
Want the complete research review?
View Full Klow 80mg Research Page→FOR RESEARCH USE ONLY
This content is provided for educational and informational purposes only. Products are furnished for in-vitro studies only and are not medicines, drugs, or supplements. Not approved by the FDA to prevent, treat, or cure any condition.
